Notices. DEPARTMENT OF HEALTH AND HUMAN SERVICES

552 words·~3 min read·/register/2025/08/19/2025-15743·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4165-15-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center For Scientific Review; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* Center for Scientific Review Special Emphasis Panel;

Clinical and Translational Cancer Research. *Date:* October 15-16, 2025. *Time:* 10:00 a.m. to 5:00 p.m. *Agenda:* To review and evaluate grant applications. *Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. *Meeting Format:* Virtual Meeting. *Contact Person:* Shuli Xia, Ph.D., Scientific Review Officer, Cancer Therapeutics Branch, Center for Scientific Review, National Institutes of Health, 9609 Medical Center Drive, Room 7W236, Rockville, Maryland 20850, 240-276-5256, *shuli.xia@nih.gov.* *Name of Committee:* Applied Therapeutics for Cancer Integrated Review Group;

Mechanisms of Cancer Therapeutics A Study Section. *Date:* October 20-21, 2025. *Time:* 9:00 a.m. to 6:00 p.m. *Agenda:* To review and evaluate grant applications. *Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. *Meeting Format:* Virtual Meeting. *Contact Person:* Careen K. Tang-Toth, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD 20892, 301-435-3504, *tothct@csr.nih.gov.* *Name of Committee:* Center for Scientific Review Special Emphasis Panel;

Clinical and Translational Cancer Research. *Date:* October 22-23, 2025. *Time:* 9:00 a.m. to 6:00 p.m. *Agenda:* To review and evaluate grant applications. *Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. *Meeting Format:* Virtual Meeting. *Contact Person:* Viktoriya Sidorenko, Ph.D., Scientific Review Officer, Cancer Therapeutics Branch, Center for Scientific Review, National Institutes of Health, 9609 Medical Center Drive, Room 7W526, Rockville, MD 20850, 240-276-5073, *viktoriya.sidorenko@nih.gov.* *Name of Committee:* Applied Therapeutics for Cancer Integrated Review Group;

Radiation Therapeutics and Biology Study Section. *Date:* October 27-28, 2025. *Time:* 8:30 a.m. to 6:00 p.m. *Agenda:* To review and evaluate grant applications. *Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. *Meeting Format:* Virtual Meeting. *Contact Person:* Bo Hong, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6194, MSC 7804, Bethesda, MD 20892, 301-996-6208, *hongb@csr.nih.gov.* *Name of Committee:* Center for Scientific Review Special Emphasis Panel;

Topics and Basic Cancer Biology. *Date:* October 27-28, 2025. *Time:* 9:00 a.m. to 6:00 p.m. *Agenda:* To review and evaluate grant applications. *Address:* National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. *Meeting Format:* Virtual Meeting. *Contact Person:* E. Tian, Ph.D., Scientific Review Officer, Basic and Translational Cancer Branch, Center for Scientific Review, National Institutes of Health, 9609 Medical Center Drive, Room 7W316, Rockville, MD 20850, 240-276-7246, *tiane@mail.nih.gov.* (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated:

August 14, 2025. Bruce A. George, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2025-15743 Filed 8-18-25; 8:45 am]